Sheel Biotech Limited
Bookbuilding IPO · NSE
- Price band
- ₹59 - ₹63
- Lot size
- 2,000 shares
- Issue amount
- ₹34.02 cr
- Total subscription
- 16.05×
- Opens
- 30 Sept 2025
- Closes
- 3 Oct 2025
- Allotment
- 6 Oct 2025
- Listing
- 8 Oct 2025
Offer at a glance
Issue overview
- Issue size
- 54,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,18,000
- Fresh issue
- ₹34.02 cr
- Offer for sale
- ₹0 cr
- Registrar
- Skyline Financial Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,26,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,49,52,550
- Shares after issue
- 2,03,52,550
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 2 | 4,000 | ₹2,52,000 |
| sHNI | 3 | 6,000 | ₹3,78,000 |
| bHNI | 8 | 16,000 | ₹10,08,000 |
Share reservation
Subscription & GMP
Subscription by category
Reported 3 Oct 2025
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 18 |
| NIB | 0 | 1,363 |
| RETAIL | 451 | 4,315 |
| HNIs(10L +) | 86 | 761 |
| HNIs (2-10L) | 43 | 602 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 6.46 | 127.54 |
| FIIs | 0 | 37.43 |
| Others | 0 | 90.1 |
| RETAIL | 11.37 | 108.74 |
| HNIs 2+ | 1.63 | 23.66 |
| HNIs 10+ | 3.25 | 104.55 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 7.21 | 7.22 | 3.5 |
| ROE | 13.59 | 15.38 | 8.23 |
| ROCE | 0 | 0 | 0 |
| RONW | 13.59 | 15.38 | 8.23 |
| PRE IPO(PE) | 8.96 | 0 | 0 |
| POST IPO(PE) | 44.07 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Sheel Biotech Limited | NA | NA | 10 | 56.84 | 13.59 | 7.21 |
| Jain Irrigation Systems Limited | 143.97 | 51.83 | 2 | 72.07 | 0.5 | 0.36 |
| Vrundavan Plantation Limited | 14.24 | 47 | 10 | 44.63 | 7.39 | 3.3 |
Company information
Company profile
Sheel Biotech Limited, incorporated in November 1991, specializes in biotechnology, floriculture, greenhouses, and organic farming. The company produces high-quality, disease-free plants for fruits, vegetables, ornamentals, and field crops using tissue culture and hydroponics, and provides greenhouse manufacturing, farmer services, and training through FPOs. It also offers landscaping services to government and private clients and holds ISO certifications for quality, environment, and safety. Its R&D lab is recognized by India’s Department of Biotechnology and Department of Science and Technology. Sheel Biotech supports organic farming adoption, manages FPOs, implements turnkey horticultural projects with modern technologies, and conducts training programs for farmers and agripreneurs. As of September 30, 2024, it had 160 permanent employees.
Strengths
- Biotechnology and Greenhouse Expertise: Skilled in tissue culture, organic farming, and modern horticultural technologies.
- Wide Product and Service Range: Offers planting materials, turnkey greenhouse projects, organic certification, FPO support, and training.
- Sustainability and Recognition: Follows eco-friendly practices and holds government-recognized R&D and international quality, safety, and environmental certifications.
Risk factors
- Strict Precision in Tissue Culture: Lapses in sterilization, storage, or temperature control can lead to contamination and significant losses.
- Dependence on Government Tenders: Revenue from organic farming heavily relies on winning tenders, making it vulnerable to policy or tender changes.
- Operational Risks in Production: Small errors in tissue culture processes can disrupt the entire production cycle.
Promoters
Dr. Satya Narayan Chandak
Mr. Sanjay Chandak
Mr. Divye Chandak
Mrs. Mini Chadha
M/s Satya Narayan Chandak (HUF)
M/s Sanjay Chandak (HUF)
M/s Sumeet Chandak (HUF)
Registrar & documents
Lead manager
Narnolia Financial Services Limited
Registrar & contacts
Skyline Financial Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
8 Balaji Estates , 2nd Floor, Block-C, Guru Ravidas Marg Kalkaji South Delhi, New Delhi, 110019
+91 88511 - 8980
[email protected]Company website ↗Frequently Asked Questions
What is Sheel Biotech IPO GMP today?
As of today, Sheel Biotech IPO Grey Market Premium (GMP) is reported at +₹15 per share. Based on the upper price band of ₹63, the estimated listing price is ₹78 (+23.8% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Sheel Biotech IPO?
The minimum bid lot size for Sheel Biotech IPO is 2,000 shares. At the cut-off price of ₹63 per share, retail investors need a minimum application amount of ₹1,26,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Sheel Biotech IPO allotment status be announced?
The allotment status for Sheel Biotech IPO is scheduled to be finalized on 6 Oct 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Skyline Financial Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Sheel Biotech IPO allotment status online by PAN?
To check Sheel Biotech IPO allotment status: 1) Visit the registrar portal (Skyline Financial Services Private Limited) or the BSE IPO allotment page. 2) Select 'Sheel Biotech Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.